Epithelial carcinoma cells acquire a motile phenotype via EMT, enabling the gain of metastatic potentials, whereas metastatic tumor cells often display a mesenchymal phenotype with a loss of epithelial markers, such as E-cadherin. Here, CDH1 is linked to neoplasm.